Group 1 - US stock index futures are showing slight gains, with Dow futures up 0.08%, S&P 500 futures up 0.06%, and Nasdaq futures up 0.06% [1] - Cryptocurrency-related stocks are rising following the US House passing three legislative proposals regarding stablecoins and cryptocurrency regulation, with Circle up 2.94% and Coinbase up 1.89% [1] - Chinese concept stocks are also experiencing gains, with Bilibili up 3.37%, Alibaba up 2.37%, and NetEase up 1.96% [1] - Nvidia's H20 chip sales to China have been approved, leading to a 7.01% increase in Kingsoft Cloud's stock [1] - Charles Schwab is set to release its Q2 earnings report, with expectations of $5.723 billion in revenue, a 22.03% year-over-year increase, and an EPS of $1.05, a 59.09% increase year-over-year, resulting in a 2.15% stock rise [1] Group 2 - GlaxoSmithKline's cancer drug Blenrep faced a setback as the FDA advisory panel voted against its use for treating relapsed or refractory multiple myeloma, causing the stock to drop 1.4% [2] - Barclays raised TSMC's target price from $249 to $275 while maintaining an "overweight" rating on the stock [2] - Mark Zuckerberg has reached a settlement with Meta shareholders regarding an $8 billion privacy lawsuit, although the final compensation amount remains unclear [2] Group 3 - Netflix reported Q2 earnings exceeding $3 billion, with revenue of $11.08 billion, a 16% year-over-year increase, and a profit of $3.1 billion, a 46% year-over-year increase [3]
【美股盘前】中概股普涨;加密货币概念股集体走高;扎克伯格与Meta股东和解,了结80亿美元脸书隐私案;癌症药物遭FDA否决,葛兰素史克跌逾1%
Mei Ri Jing Ji Xin Wen·2025-07-18 11:02